JP MORGAN/CALL/ELI LILLY & CO/920/0.1/21.06.24 Share Price

Warrant

DE000JB4NTX4

Market Closed - Börse Stuttgart 01:11:35 14/06/2024 pm IST
0.3 EUR +36.36% Intraday chart for JP MORGAN/CALL/ELI LILLY & CO/920/0.1/21.06.24
Current month+66.67%
1 month+289.61%
Date Price Change
14/24/14 0.3 +36.36%
13/24/13 0.22 -21.43%
12/24/12 0.28 +27.27%
11/24/11 0.22 -12.00%
10/24/10 0.25 +92.31%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 01:11 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ELI LILLY AND COMPANY
Issuer J.P. Morgan
WKN JB4NTX
ISINDE000JB4NTX4
Date issued 18/10/2023
Strike 920 $
Maturity 21/06/2024 (6 Days)
Parity 10 : 1
Emission price 0.79
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.16
Lowest since issue 0.075
Delta0x
Omega 0.000000
Premium0x
Gearing0x
Moneyness 0.9548
Difference Strike 41.55 $
Difference Strike %+4.52%
Intrinsic value 0.000000

Company Profile

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows: - endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems; - oncology (19.5%); - immunology diseases (11.1%); - neurology (8.4%): primarily drugs used in treating depression and schizophrenia; - other (3.3%). Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
More about the company

Ratings for Eli Lilly and Company

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Eli Lilly and Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
878.4 USD
Average target price
855.4 USD
Spread / Average Target
-2.63%
Consensus